Concepedia

Eduardo Forleo‐Neto

EF

Statistics

Publications

26

Citations

1.8K

H-Index

18

Active since

1997

Affiliations

Regeneron (United States)(Current)

Novartis (United States)

University of North Carolina at Chapel Hill

University of Pennsylvania

Fred Hutch Cancer Center

Eduardo Forleo‐Neto is an author at Regeneron (United States) specializing in vaccination, medicine, and vaccine safety.

ORCID

Top concepts

Publications per year

1997–2023

26

Publications

26

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

Meagan P. O’Brien, Eduardo Forleo‐Neto, Bret J. Musser et al. · New England Journal of Medicine · 2021 · 470 citations · Full text

Antigenic and Genetic Variability of Human Metapneumoviruses

Bernadette G. van den Hoogen, Sander Herfst, Leo Sprong et al. · Emerging infectious diseases · 2004 · 406 citations · Full text

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

Eric A. F. Simões, Eduardo Forleo‐Neto, Gregory P. Geba et al. · Clinical Infectious Diseases · 2020 · 143 citations · Full text

Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects

Sharon E. Frey, Mari Rose Aplasca-De Los Reyes, Humberto Reynales et al. · Vaccine · 2014 · 136 citations

, , +9

Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

Stephan Bart, Kevin Cannon, Darrell T. Herrington et al. · Human Vaccines & Immunotherapeutics · 2016 · 56 citations · Full text

, , +20

Rows per page

1–5 of 26